1500 patients on free benefits for Gleevec treatment.

Published: 2006-04-17 06:57:00

Updated: 2006-04-17 06:57:00

During the past 7 months about 1,500 patients with chronic myeloid leukemia have received a full NHI coverage benefit for Gleevec medication according to Novartis Korea.

Novartis Korea has provided "Patient supporting program for Gleevec" by supporting to pay 10% out of 20% of patient's own po...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK